Lymphoepithelioma is a nonkeratinizing squamous cell carcinoma with Epstein-Barr virus infection in China

Journal of Cancer Research and Therapeutics

Volumn 13, Issue 5, 2017, Pages 807-812

  He, Qiuyan ^a   Zhou, Yangying ^b   Fu, Chunyan ^a   Zhu, Wei ^a   Zhou, Jianhua ^a   Liu, Shuang ^b   Tao, Yongguang ^a,c,d   Xiao, Desheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Key Laboratory of Carcinogenesis and Cancer Invasion   (India)

^d National Health and Family Planning Commission   (China)

Author keywords

Epstein Barr virus; lymphoepithelial carcinoma; squamous cell carcinoma

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; PROTEIN P40; PROTEIN P63; VIRUS RNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CHINA; CLINICAL ARTICLE; EPSTEIN BARR VIRUS INFECTION; FEMALE; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOEPITHELIOMA; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; BIOMARKERS; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CELL NUCLEUS; CHINA; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; RNA, VIRAL;

EID: 85038837894     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/jcrt.JCRT_280_17     Document Type: Article

References (45)

1. Hilderman WC, Gordon JS, Large HL Jr., Carroll CF Jr. Malignant lymphoepithelial lesion with carcinomatous component apparently arising in parotid gland. A malignant counterpart of benign lymphoepithelial lesion? Cancer 1962;15:606-10.
2. Thompson L. World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Ear Nose Throat J 2006;85:74.
3. Olmez S, Can A, Yavuz A, Iliklerden UH, Bulut G. Esophageal lymphoepithelioma-like carcinoma with unique daisy-like appearance. Clin Endosc 2015;48:549-52.
4. Ma H, Lin Y, Wang L, Rao H, Xu G, He Y, et al. Primary lymphoepithelioma-like carcinoma of salivary gland: Sixty-nine cases with long-term follow-up. Head Neck 2014;36:1305-12.
5. Liang Y, Wang L, Zhu Y, Lin Y, Liu H, Rao H, et al. Primary pulmonary lymphoepithelioma-like carcinoma: Fifty-two patients with long-term follow-up. Cancer 2012;118:4748-58.
6. He J, Shen J, Pan H, Huang J, Liang W, He J. Pulmonary lymphoepithelioma-like carcinoma: A Surveillance, Epidemiology, and End Results database analysis. J Thorac Dis 2015;7:2330-8.
7. Xu L, Zheng J, Li J, Shi L, Fan S. Role of Wnt5a and LMP1 in the nasopharyngeal carcinogenesis by high-throughput tissue microarray technology. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012;37:865-70.
8. Nagai T, Naiki T, Kawai N, Iida K, Etani T, Ando R, et al. Pure lymphoepithelioma-like carcinoma originating from the urinary bladder. Case Rep Oncol 2016;9:188-94.
9. Morteza Abedi S, Salama S, Alowami S. Lymphoepithelioma-like carcinoma of the skin: Case report and approach to surgical pathology sign out. Rare Tumors 2013;5:e47.
10. Min BH, Tae CH, Ahn SM, Kang SY, Woo SY, Kim S, et al. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma. Gastric Cancer 2016;19:852-9.
11. Kaul R, Gupta N, Sharma J, Gupta S. Lymphoepithelioma-like carcinoma of the uterine cervix. J Cancer Res Ther 2009;5:300-1.
12. Xiao D, Shi Y, Fu C, Jia J, Pan Y, Jiang Y, et al. Decrease of TET2 expression and increase of 5-hmC levels in myeloid sarcomas. Leuk Res 2016;42:75-9.
13. Khan H, Gupta S, Husain N, Misra S, Singh N, Negi MP. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. J Cancer Res Ther 2014;10:258-64.
14. Xiao D, Huang J, Pan Y, Li H, Fu C, Mao C, et al. Chromatin remodeling factor LSH is upregulated by the LRP6-GSK3s-E2F1 axis linking reversely with survival in gliomas. Theranostics 2017;7:132-43.
15. Xiao D, Jia J, Shi Y, Fu C, Chen L, Jiang Y, et al. Opposed expression of IKKa: Loss in keratinizing carcinomas and gain in non-keratinizing carcinomas. Oncotarget 2015;6:25499-505.
16. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10:1243-60.
17. Ke K, Wang H, Fu S, Zhang Z, Duan L, Liu D, et al. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma. Chin Med J (Engl) 2014;127:294-9.
18. Adham M, Greijer AE, Verkuijlen SA, Juwana H, Fleig S, Rachmadi L, et al. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment. Clin Cancer Res 2013;19:2175-86.
19. Hayashi T, Haba R, Tanizawa J, Katsuki N, Kadota K, Miyai Y, et al. Cytopathologic features and differential diagnostic considerations of primary lymphoepithelioma-like carcinoma of the lung. Diagn Cytopathol 2012;40:820-5.
20. Terzic TT, Boricic MI, Pendjer IP, Ruzic Zecevic DT, Tomanovic NR, Brasanac DC, et al. Prognostic significance of clinical parameters and Epstein-Barr virus infection in non-endemic undifferentiated carcinoma of nasopharyngeal type: A Serbian report. Med Oncol 2011;28:1325-30.
21. Terada T. Epstein-Barr virus associated lymphoepithelial carcinoma of the esophagus. Int J Clin Exp Med 2013;6:219-26.
22. Righi L, Graziano P, Fornari A, Rossi G, Barbareschi M, Cavazza A, et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: A retrospective study of 103 cases with surgical correlation. Cancer 2011;117:3416-23.
23. Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011;35:15-25.
24. Wang BY, Gil J, Kaufman D, Gan L, Kohtz DS, Burstein DE. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 2002;33:921-6.
25. Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med 2012;136:155-62.
26. Tsuta K, Tanabe Y, Yoshida A, Takahashi F, Maeshima AM, Asamura H, et al. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung. J Thorac Oncol 2011;6:1190-9.
27. Hallack Neto AE, Siqueira SA, Dulley FL, Ruiz MA, Chamone DA, Pereira J. p63 protein expression in high risk diffuse large B-cell lymphoma. J Clin Pathol 2009;62:77-9.
28. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 2000;97:5462-7.
29. Bir F, Aksoy Altinboga A, Satiroglu Tufan NL, Kaya S, Baser S, Yaren A. Potential utility of p63 expression in differential diagnosis of non-small-cell lung carcinoma and its effect on prognosis of the disease. Med Sci Monit 2014;20:219-26.
30. Pelosi G, Sonzogni A, Papotti M. Different prevalence of transactivating (TA) p63 and non-TAp63 isoforms in pulmonary adenocarcinomas: A useful diagnostic tool. Mod Pathol 2010;23:411A-2A.
31. Nonaka D. A study of Np63 expression in lung non-small cell carcinomas. Am J Surg Pathol 2012;36:895-9.
32. Berghmans T, Paesmans M, Mascaux C, Martin B, Meert AP, Haller A, et al. Thyroid transcription factor 1-A new prognostic factor in lung cancer: A meta-analysis. Ann Oncol 2006;17:1673-6.
33. Downey P, Cummins R, Moran M, Gulmann C. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung. APMIS 2008;116:526-9.
34. Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970;228:1056-8.
35. Bégin LR, Eskandari J, Joncas J, Panasci L. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung. J Surg Oncol 1987;36:280-3.
36. Weiss LM, Gaffey MJ, Shibata D. Lymphoepithelioma-like carcinoma and its relationship to Epstein-Barr virus. Am J Clin Pathol 1991;96:156-8.
37. Jang SJ, Paik SS, Lee WM, Park YW, Jang KJ, Tae K, et al. Lymphoepithelial carcinoma of the submandibular gland-A case report. J Korean Med Sci 1997;12:252-5.
38. Jen KY, Cheng J, Li J, Wu L, Li Y, Yu S, et al. Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas. Int J Cancer 2003;105:654-60.
39. Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: Demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol 1991;22:811-5.
40. Anantharajan N, Ravindranathan N, Rajadurai P. Lymphoepithelial carcinoma of the parotid gland, a very unusual tumor: Case report and review. Ear Nose Throat J 2013;92:E7-9.
41. Menditti D, Laino L, Milano M, Caputo C, Boccellino M, D'Avino A, et al. Intraoral lymphoepithelial carcinoma of the minor salivary glands. In Vivo 2012;26:1087-9.
42. Tang CG, Schmidtknecht TM, Tang GY, Schloegel LJ, Rasgon B. Lymphoepithelial carcinoma: A case of a rare parotid gland tumor. Perm J 2012;16:60-2.
43. Gupta S, Loh KS, Petersson F. Lymphoepithelial carcinoma of the parotid gland arising in an intraglandular lymph node: Report of a rare case mimicking metastasis. Ann Diagn Pathol 2012;16:416-21.
44. Tao Y, Shi Y, Jia J, Jiang Y, Yang L, Cao Y. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma. Expert Rev Mol Med 2015;17:e15.
45. Shi Y, Peng SL, Yang LF, Chen X, Tao YG, Cao Y. Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chin J Cancer 2016;35:16.